Medical Marijuana Product Advancements Propelling Cannabis Industry As Revenues From Sales Forecasted For Exponential Growth
Date : 07/20/2016 @ 8:30AM
Source : InvestorsHub NewsWire
Stock : Rocky Mountain High Brands, Inc. (PC) (RMHB)
Quote : 0.0309 -0.0006 (-1.90%) @ 4:41PM
Medical Marijuana Product Advancements Propelling Cannabis Industry As Revenues From Sales Forecasted For Exponential Growth
Medical Marijuana Product Advancements Propelling Cannabis Industry As Revenues From Sales Forecasted For Exponential Growth
Coral Springs, FL -- July 20, 2016 -- InvestorsHub NewsWire -- The medical marijuana sector shows no signs of slower growth as more states & Global governments push towards legalization while revenue opportunities continue to steadily rise. Experts are forecasting medical marijuana revenues to significantly top $20 Billion by the year 2020.
New Colombia Resources, Inc. (OTC: NEWC), a Colombian company listed in the U.S., is pleased that Sannabis SAS, their Medical Marijuana joint venture, continues to make headlines. Sannabis products were showcased at an inaugural event for Caucannabis, Colombias first medical marijuana co-operative that includes 52 Indigenous families that will legally grow medical marijuana. Caucannabis was formed by mayors of the Department of Cauca, home to Sannabis and Colombias largest marijuana growing region, where 50% of the nations marijuana is grown. The inauguration made major headlines due the visit from Colombias Ministers of Justice and Health who support this co-operative. To see all the press Sannabis is getting, visit the News page of their new and improved website,http://www.sannabis.co/#!blog/csjb/
Read the full New Colombia Resources (NEWC) Press Release at: http://financialnewsmedia.com/profiles/newc.html
Sannabis has been growing medical marijuana and producing high quality, organic products in Cauca since 2014. In April they hosted the mayors of the Cauca Department at their facilities to be used as a model for the co-op. Sannabis is increasing their production to satisfy the demand for medical marijuana medicines, the addition of the co-op will add to the Sannabis supply chain. The Sannabis portfolio of medical products has a first to market advantage which is causing huge international demand and Sannabis is fielding interest for their products from all over the World. We expect to be the first ones with significant products to export that are Made in Colombia, we have experts in marijuana cultivation from Colorado and Washington on their way to Cauca by the end of the month to teach the indigenous community U.S. techniques and vice versa, stated John Campo, President of New Colombia Resources, Inc. Mr. Campo was recently interviewed by Stock Traders Talk Radio; an archived recorded version can be found on the homepage of Stock Traders Talk atwww.stocktraderstalk.com.
In other cannabis/marijuana news and developments: Worldwide the number of people living with diabetes has reached 422 million, and if the current trend continues, over 700 million people are expected to be living with diabetes by 2025. Diabetes has clearly become a healthcare crisis on a global scale, and PharmaCyte Biotech (OTC: PMCB) (OTCQB: PMCB) recently received some good news in the form of patent protection that will help the company do its part in bringing a treatment to tens of millions of these patients. PharmaCyte recently learned from the U.S. Patent and Trademark Office (USTPO) that it now has 20 years of patent protection in the United States for the "Melligen" cells that are a part of the company's therapy for Type 1 and insulin-dependent Type 2 diabetes. The timing is perfect because the same research that laid out the dramatic rise in the numbers of people affected by diabetes, also found that the global cost of diabetes has ballooned to $825-billion per year.
Oxis International Inc. (OTC: OXIS) (OTCQB: OXIS) announced that the company's innovative cancer therapies will be profiled on Fox Business Network onSunday, July 24, at 12:30 p.m. Eastern time. Anthony J. Cataldo, chief executive of Oxis, discussed the company's drugs for the treatment of cancer and other unmet medical needs on the program Worldwide Business with Kathy Ireland.
Rocky Mountain High Brands, Inc. (OTC: RMHB) announced recently that the Company will go on tour as a sponsor to the red-hot Oklahoma-based country influenced rockers, Hillbilly Vegas. The three-year sponsorship agreement will include product promotional support at concert events, photo shoots, distribution of promotional items, music content, promotional appearances and a vehicle wrap of the band's 42 ft. tour bus.
Medical Marijuana, Inc. (OTC: MJNA) announced earlier this month that the Paraguay government has issued a new import permit for the Company's flagship product Real Scientific Hemp Oil (RSHO) for a new patient in the country. The Company also announced its plans to further expand into Latin America as the cannabis industry continues gaining ground in the region and as demand for its products increase. The Paraguay government granted the country's first-ever import permit for RSHO in May 2016, which marked the third country in Latin America, after Brazil and Mexico to approve Medical Marijuana, Inc.'s cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson's disease and chronic pain. RSHO also has 12 medical product registrations in Puerto Rico.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
.
Date : 07/20/2016 @ 8:30AM
Source : InvestorsHub NewsWire
Stock : Rocky Mountain High Brands, Inc. (PC) (RMHB)
Quote : 0.0309 -0.0006 (-1.90%) @ 4:41PM
Medical Marijuana Product Advancements Propelling Cannabis Industry As Revenues From Sales Forecasted For Exponential Growth
Medical Marijuana Product Advancements Propelling Cannabis Industry As Revenues From Sales Forecasted For Exponential Growth
Coral Springs, FL -- July 20, 2016 -- InvestorsHub NewsWire -- The medical marijuana sector shows no signs of slower growth as more states & Global governments push towards legalization while revenue opportunities continue to steadily rise. Experts are forecasting medical marijuana revenues to significantly top $20 Billion by the year 2020.
New Colombia Resources, Inc. (OTC: NEWC), a Colombian company listed in the U.S., is pleased that Sannabis SAS, their Medical Marijuana joint venture, continues to make headlines. Sannabis products were showcased at an inaugural event for Caucannabis, Colombias first medical marijuana co-operative that includes 52 Indigenous families that will legally grow medical marijuana. Caucannabis was formed by mayors of the Department of Cauca, home to Sannabis and Colombias largest marijuana growing region, where 50% of the nations marijuana is grown. The inauguration made major headlines due the visit from Colombias Ministers of Justice and Health who support this co-operative. To see all the press Sannabis is getting, visit the News page of their new and improved website,http://www.sannabis.co/#!blog/csjb/
Read the full New Colombia Resources (NEWC) Press Release at: http://financialnewsmedia.com/profiles/newc.html
Sannabis has been growing medical marijuana and producing high quality, organic products in Cauca since 2014. In April they hosted the mayors of the Cauca Department at their facilities to be used as a model for the co-op. Sannabis is increasing their production to satisfy the demand for medical marijuana medicines, the addition of the co-op will add to the Sannabis supply chain. The Sannabis portfolio of medical products has a first to market advantage which is causing huge international demand and Sannabis is fielding interest for their products from all over the World. We expect to be the first ones with significant products to export that are Made in Colombia, we have experts in marijuana cultivation from Colorado and Washington on their way to Cauca by the end of the month to teach the indigenous community U.S. techniques and vice versa, stated John Campo, President of New Colombia Resources, Inc. Mr. Campo was recently interviewed by Stock Traders Talk Radio; an archived recorded version can be found on the homepage of Stock Traders Talk atwww.stocktraderstalk.com.
In other cannabis/marijuana news and developments: Worldwide the number of people living with diabetes has reached 422 million, and if the current trend continues, over 700 million people are expected to be living with diabetes by 2025. Diabetes has clearly become a healthcare crisis on a global scale, and PharmaCyte Biotech (OTC: PMCB) (OTCQB: PMCB) recently received some good news in the form of patent protection that will help the company do its part in bringing a treatment to tens of millions of these patients. PharmaCyte recently learned from the U.S. Patent and Trademark Office (USTPO) that it now has 20 years of patent protection in the United States for the "Melligen" cells that are a part of the company's therapy for Type 1 and insulin-dependent Type 2 diabetes. The timing is perfect because the same research that laid out the dramatic rise in the numbers of people affected by diabetes, also found that the global cost of diabetes has ballooned to $825-billion per year.
Oxis International Inc. (OTC: OXIS) (OTCQB: OXIS) announced that the company's innovative cancer therapies will be profiled on Fox Business Network onSunday, July 24, at 12:30 p.m. Eastern time. Anthony J. Cataldo, chief executive of Oxis, discussed the company's drugs for the treatment of cancer and other unmet medical needs on the program Worldwide Business with Kathy Ireland.
Rocky Mountain High Brands, Inc. (OTC: RMHB) announced recently that the Company will go on tour as a sponsor to the red-hot Oklahoma-based country influenced rockers, Hillbilly Vegas. The three-year sponsorship agreement will include product promotional support at concert events, photo shoots, distribution of promotional items, music content, promotional appearances and a vehicle wrap of the band's 42 ft. tour bus.
Medical Marijuana, Inc. (OTC: MJNA) announced earlier this month that the Paraguay government has issued a new import permit for the Company's flagship product Real Scientific Hemp Oil (RSHO) for a new patient in the country. The Company also announced its plans to further expand into Latin America as the cannabis industry continues gaining ground in the region and as demand for its products increase. The Paraguay government granted the country's first-ever import permit for RSHO in May 2016, which marked the third country in Latin America, after Brazil and Mexico to approve Medical Marijuana, Inc.'s cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson's disease and chronic pain. RSHO also has 12 medical product registrations in Puerto Rico.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
.
2
